DJIA 17,164.95 -251.90 -1.45%
NASDAQ 4,635.24 -48.17 -1.03%
S&P 500 1,994.99 -26.26 -1.30%
market minute promo

Amarin Corp plc (ADR) (NASDAQ: AMRN)

1.02 -0.01 (-0.97%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

AMRN $1.02 -0.97%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $1.01
Previous Close $1.03
Daily Range $1.01 - $1.05
52-Week Range $0.78 - $2.09
Market Cap $178.1M
P/E Ratio -2.02
Dividend (Yield) $0.00 (0.0%)
Volume 532,251
Average Daily Volume 1,355,438
Current FY EPS -$0.47





Amarin Corp plc (ADR) (AMRN) Description

The Company is engaged in the research, development and commercialization of novel drugs for the treatment of central nervous system disorders. Website:

News & Commentary Rss Feed

Why Amarin Corporation PLC Stock Flew 37% Higher in November

Amarin shares rocket higher in November after the company released exciting new data on Vascepa. But will it be enough to sustain the rally more than a few weeks?

Amarin's Reduced Cash Burn Makes Dilution Less Likely

Update: Amarin Estimates A $120 Million Year-End Cash Balance

Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 4

Amarin: Kowa Co-Promotion Agreement May Be Boosting Sales

European ADRs Lifted by Pharmaceutical Stock Gains

Good News: Vascepa Kept Its Place On National Formularies

Amarin Corporation: Upside Becomes Clearer While The Path To The Finish Line Remains Murky

Amarin: The Silence Of The Lamb

Update: Amarin Earnings Show It Blew Its Chance At 2014 Profitability

See More AMRN News...

AMRN's Top Competitors

AMRN $1.02 (-0.97%)
Current stock: AMRN
JNJ $100.14 (-2.19%)
Current stock: JNJ
NVS $97.40 (-1.77%)
Current stock: NVS
RHHBY $33.78 (-1.75%)
Current stock: RHHBY